Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples